Is chemotherapy implicated in the development of hypopituitarism in childhood cancer survivors?
Endocrine sequelae are a frequent result of therapy aimed at inducing remission in childhood cancer survivors. Hypopituitarism is the consequence of insults directed at the hypothalamo-pituitary axis, in particular surgery and radiotherapy. The question of whether chemotherapy, in the absence of concomitant radiotherapy, can induce hypopituitarism in susceptible individuals has been raised by a number of studies over the last 30 years. Where described the pituitary hormone deficit in question is almost exclusively growth hormone. Studies have been of variable quality, with endocrine testing that fails to hold up to scrutiny. There is thus no robust data to support this hypothesis, in particular no single agent or class of chemotherapeutic agent has been implicated, and the mechanism of action remains elusive.